OrganiGram Holdings OGI Stock Price, News, Charts benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
10 Best Weed Stocks to Buy Now
While the coronavirus pandemic has wreaked havoc on many industries around the world, the weed industry proved to be antifragile and grew in the period amid rising sales, legalization, medical and recreational benefits. Legal cannabis made history in 2020, with states like New Jersey, Montana, and South Dakota voting to legalize recreational cannabis, as well as states like Arizona and Mississippi approving it.
Cannabis production is already one of the fastest-growing industries globally, but the year 2020 has taken it to the next tier. According to
BDSA, a leading cannabis industry research firm, global cannabis revenues hit approximately $21.3 billion in 2020, up 48% from $14.4 billion in 2019. The growing acceptance of marijuana in society and the legalization of cannabis both for medical and recreational use are the major growth catalysts driving the cannabis industry. Global cannabis revenues are expected to increase by more than 17%, from
Press release content from Business Wire. The AP news staff was not involved in its creation.
Organigram Expands Edison Cannabis Co. Dried Flower Portfolio with Two New High THC Strains: GMO Cookies and MAC-1
April 22, 2021 GMT
MONCTON, New Brunswick (BUSINESS WIRE) Apr 22, 2021
As part of the continued expansion of its Edison Cannabis Co. (“Edison”) line of products, Organigram Holdings Inc. (“
Organigram ” or the “
Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new Edison dried flower strains including the potent GMO Cookies and legendary citrus diesel MAC-1.
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) reported Tuesday that gross revenue decreased by 29% year-over-year to roughly CA$19.3 million ($15.4 million) in the second quarter of fiscal 2021.
Net revenue also declined over the same period, from CA$23.2 million to CA$14.6 million, the Moncton, New Brunswick-based company said in a statement.
The second-quarter results were challenged by industry dynamics, COVID-19 and staffing limitations at our facility, CEO Greg Engel said in a statement.
Yet there are excellent prospects ahead for the industry, Organigram and our shareholders, he added.
Organigram Financial Highlights
The second-quarter gross margin came in negative, at CA$17.2 million, representing a year-over-year decrease of 252% from the positive CA$11.3 million reported in the same quarter last year.